Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the United States

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create these jobs between 2028 and 2032 at an average yearly salary of at least $119,800.

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States amid President Donald Trump's tariff policies.

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma’s “next generation” weight loss drug.

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.

The move is part of Roche’s previously announced plan to invest $50 billion in pharmaceuticals and diagnostics over the next five years in the United States. Roche Diagnostics, with its North America unit based in Indianapolis, is a maker of instruments to help physicians and laboratories test for a wide range of patient conditions.

AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international reputation, are delighted to announce the extension of their partnership for a

The National Health Insurance Authority has signed an expanded Memorandum of Understanding with a leading multinational healthcare company, Roche, to enhance access to affordable cancer care and treatment.